Anticoagulation-related morbidity and mortality rates were 0.67% and 0.15% Pty major hemorrhage morbidity and mortality rates were 0.25% and 0.13% Pty thromboembolism morbidity and mortality rates were 0.45% and 0.03% Pty.The mean dosage of warfarin daily dosage was (2.85☑.23) mg/d and INR value was 1.82☐.57.No significant regional difference in the intensity of anticoagulation therapy was noted during the study. In this multicenter prospective cohort study, the anticoagulation and monitoring strategy data was acquired from 25 773 in-hospital patients in 35 medical centers and 20 519 patients in outpatient clinic in 11 medical centers from January 1st, 2011 to December 31th, 2015.Īs for in-hospital patients, mean age of study population was (48.6☑1.2) years old main etiology of valve pathology was rheumatic (87.5%) origin among study cohort 94.8% of study population received mechanical valve implantation international normalized ratio (INR) monitoring (in all the study centers) and low-intensity anticoagulation strategy (31 hospitals chose target INR range of 1.5-2.5, and actual values of INR among 89.2% of 100 069 in-hospital monitoring samples were 1.5-2.5), with mean actual INR values of 1.84☐.53, and warfarin dosage of (2.82☐.93) mg/d were widely adopted among the study centers strategies of in-hospital warfarin administration were similar in all the study centers complication rates of low-intensity anticoagulation strategy were low in severe hemorrhage (0.02%), thrombosis (0.05%), and thromboembolism (0.05%) events, without anticoagulation-related death.As for 18 974 outpatient clinic patients, the follow-up rate was 92.47%, with a total of 30 012 patient-years (Pty). Some of these formulas are made by these 2 brands.To investigate the optimal anticoagulation methods and monitoring strategy for Chinese patients undergoing heart valve replacement, which is potentially quite different from western populations. The two leading brands to export Chinese classic herbal formulas in the form of Chinese patent medicine from China are Mín Shān ( 岷山) and Plum Flower ( 梅花). It is difficult to define which of these formulas are the most common. Many are slight variations of other formula however. There are hundreds of Chinese classic herbal formulas. Chuang Song Zong Pharmaceutical Co., Ltd.Sometimes Chinese plants are substituted for plants found in Japan, or the proportions of the formula are changed slightly. These formulas are based on the Chinese classic herbal formulas.
Instead the herbalist will choose an herbal formula that has been standardized by the Japanese government. In Japan, herbalists do not create medicine for each patient. These formulas are also used in kampo ( traditional Japanese medicine). Many of these formulas are still made in the form of Chinese patent medicine. It was published in the " Xiao'er Yao Zheng Zhi Jue" (also known as "Key to Therapeutics of Children's Diseases" 小儿药证直诀 Xiǎoér yào zhèng zhí jué Hsiao-erh yao cheng chih chüeh) in 1119 by Qian Yi's student. For example, " Liu Wei Di Huang Wan" ( 六味地黄丸 liùwèi dìhuáng wán liu-wei ti-huang wan) was developed by Qian Yi ( 钱乙 Qián Yǐ) (c. Many of these formulas were created by the pioneers of Chinese medicine and are quite old. Later these students will adapt these classic formulas to match the needs of each patient. They are the basic herbal formulas that students of Traditional Chinese medicine learn. The seated woman facing the gentleman on the upper terrace seems to be playing a xiao flute. Chinese classic herbal formulas ( simplified Chinese: 经方 traditional Chinese: 經 方) are combinations of herbs used in Chinese herbology for supposed greater efficiency in comparison to individual herbs. Image: Playing the xiao flute to attract a Phoenix ( Chui Xiao Yin Feng) This painting, by Qiu Ying, in the National Palace Museum, Beijing, seems to be connected to the story of Xiao Shi and Nong Yu.
0 kommentar(er)
